A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma

Clinical trial NCT07143812 · RECRUITING

Trial details

NCT number: NCT07143812
Sponsor: CHA University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma (GBM)Newly Diagnosed Glioblastoma Multiforme

Start date: 2025-10-23
Primary completion: 2026-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.